Elite Pharmaceuticals, Inc. Restricted Cash and Cash Equivalents, Noncurrent
Elite Pharmaceuticals, Inc. (ELTP) had Restricted Cash and Cash Equivalents, Noncurrent of $432.83 thousand as of 2024-03-31, per its 10-K filed 2024-07-01.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Restricted Cash and Investments, Noncurrent
us-gaap:RestrictedCashAndCashEquivalentsNoncurrent · last filed 2024-07-01
- 2024-03-31: Restricted Cash and Cash Equivalents, Noncurrent $432.83K.
- 2023-12-31: Restricted Cash and Cash Equivalents, Noncurrent $428.00K.
- 2023-09-30: Restricted Cash and Cash Equivalents, Noncurrent $422.75K.
- 2023-06-30: Restricted Cash and Cash Equivalents, Noncurrent $415.43K.
| Period end | Restricted Cash and Cash Equivalents, Noncurrent |
|---|---|
| 2024-03-31 | $432.83K 10-K · filed 2024-07-01 |
| 2023-12-31 | $428.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $422.75K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $415.43K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $412.43K 10-K · filed 2024-07-01 |
| 2022-12-31 | $405.16K 10-Q · filed 2024-02-14 |
| 2022-09-30 | $405.16K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $405.16K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $405.04K 10-K · filed 2023-06-29 |
| 2021-12-31 | $405.03K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $405.02K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $405.01K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $405.01K 10-K · filed 2022-06-29 |
| 2020-12-31 | $405.00K 10-Q · filed 2021-02-16 |
| 2020-09-30 | $404.99K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $404.99K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $404.80K 10-K · filed 2021-06-14 |
| 2019-12-31 | $403.57K 10-Q · filed 2020-02-10 |
| 2019-09-30 | $401.47K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $398.13K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $398.13K 10-K · filed 2020-06-29 |
| 2018-12-31 | $396.13K 10-Q · filed 2019-02-11 |
| 2018-09-30 | $394.40K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $392.82K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $391.57K 10-K · filed 2019-06-21 |
| 2017-12-31 | $390.65K 10-Q · filed 2018-02-09 |
| 2017-09-30 | $390.01K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $389.39K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $389.08K 10-K · filed 2018-06-14 |
| 2016-12-31 | $388.96K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $388.96K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $388.96K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $388.96K 10-K · filed 2017-06-14 |
| 2015-12-31 | $388.96K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $388.96K 10-Q · filed 2015-12-30 |
| 2015-06-30 | $388.96K 10-Q · filed 2015-12-30 |
| 2015-03-31 | $388.96K 10-K · filed 2016-06-15 |
| 2014-12-31 | $388.95K 10-Q · filed 2015-02-17 |
| 2014-09-30 | $388.95K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $339.40K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $265.04K 10-K · filed 2015-06-15 |
| 2013-12-31 | $327.01K 10-Q · filed 2014-02-14 |
| 2013-09-30 | $295.46K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $348.65K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $267.82K 10-K · filed 2014-06-30 |
| 2012-12-31 | $343.05K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $274.03K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $321.30K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $280.58K 10-K · filed 2013-06-21 |
| 2011-12-31 | $333.25K 10-Q · filed 2012-02-14 |
| 2011-09-30 | $287.13K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $348.37K 10-Q/A · filed 2011-08-19 |
| 2011-03-31 | $291.42K 10-K · filed 2012-06-29 |